Suk, F.-M.; Wu, C.-Y.; Chiu, W.-C.; Chien, C.-Y.; Chen, T.-L.; Liao, Y.-J.
HMGCS2 Mediation of Ketone Levels Affects Sorafenib Treatment Efficacy in Liver Cancer Cells. Molecules 2022, 27, 8015.
https://doi.org/10.3390/molecules27228015
AMA Style
Suk F-M, Wu C-Y, Chiu W-C, Chien C-Y, Chen T-L, Liao Y-J.
HMGCS2 Mediation of Ketone Levels Affects Sorafenib Treatment Efficacy in Liver Cancer Cells. Molecules. 2022; 27(22):8015.
https://doi.org/10.3390/molecules27228015
Chicago/Turabian Style
Suk, Fat-Moon, Chien-Ying Wu, Wan-Chun Chiu, Chia-Ying Chien, Tzu-Lang Chen, and Yi-Jen Liao.
2022. "HMGCS2 Mediation of Ketone Levels Affects Sorafenib Treatment Efficacy in Liver Cancer Cells" Molecules 27, no. 22: 8015.
https://doi.org/10.3390/molecules27228015
APA Style
Suk, F.-M., Wu, C.-Y., Chiu, W.-C., Chien, C.-Y., Chen, T.-L., & Liao, Y.-J.
(2022). HMGCS2 Mediation of Ketone Levels Affects Sorafenib Treatment Efficacy in Liver Cancer Cells. Molecules, 27(22), 8015.
https://doi.org/10.3390/molecules27228015